Lakewood-Amedex Biotherapeutics Inc.
Lakewood-Amedex Biotherapeutics develops Bisphosphocin®, a class of broad-spectrum antimicrobials to treat infectious diseases caused by antibiotic-resistant bacteria including MRSA and VRE.
8-KSep 29Latest SEC filing, period to Sep 22
Sep 18Latest story
September 2026